Top 100 Most Insightful Quotes for Internet Healthcare Entrepreneurs (Part II): Strategic Wisdom from Industry Leaders
Day 2 of the “Xingdong Xiangyihui” Venture Capital Camp Open Lecture. Today’s guest speakers hail from a diverse range of sectors, including platform-based, vertical-focused, and smart hardware companies. The insights shared were abundant, comprehensive, and incisive. Here is a curated highlight reel.
Follow VCBeat’s WeChat account (vcbeat) to access the full version, stay updated, and save it for future reference!
————————————Highlights from Guest Speakers————————————
BlueRun Ventures’ Chen Weiguang: Internet Healthcare Projects Must Prioritize Addressing Physician Motivation
1. We all tend to optimize existing ecosystems and processes. However, entrepreneurial success is often not merely an iteration of the old “horse-drawn carriage,” but rather a disruption. Jack Ma’s success stemmed from breaking away from established business models and value chains.
2. My biggest takeaway is that many entrepreneurs recognize the numerous opportunities within the healthcare ecosystem, yet most still adhere to traditional mindsets, thereby facing significant challenges.
4. A carriage may lack horses; similarly, doctors in hospitals often exhibit weak motivation because their incentives are not linked to the outcome of successfully curing patients, leaving this causal chain perpetually distorted.
5. Regardless of the project, it is essential to address physicians' motivation, and this motivation must be relevant to the physicians you serve.
6. I place significant emphasis on building an ecosystem outside the hospital setting; if you aim to create greater user value, you must develop new service models.
7. When undertaking a project, the first step is to accurately identify the company’s positioning. Evaluating this positioning through specific metrics will provide a clearer understanding of the enterprise’s strategic direction and help you explore more suitable business models.
8. The patient-to-patient relationship follows a community model, the doctor-to-patient relationship follows a clinic model, and the doctor-to-doctor relationship follows a referral model; different combinations yield different models.
9. The main partners of mobile healthcare companies include pharmaceutical manufacturers, insurance companies, and smart hardware manufacturers.
10. It takes time for mobile health to gain recognition. Currently, there are three widely adopted models: collecting user data for pharmaceutical companies to facilitate drug recommendations and advertising; the HMO model; and managing doctor-patient relationships with fees charged to patients. All three models are profitable.
WeDoctor Group’s Lu Zigui: The Four Quadrants and Four-Character Mantra of Internet Healthcare
1. Healthcare services comprise four quadrants, including: patients, physicians, healthcare organizations, and hospitals.
2. Our corporate mantra is “Customer First.” From the outset, we adopted a fully free model and integrated our services with hospitals. Strategically, this entails focus, deep penetration, and scale.
3. Tiered diagnosis and treatment and team-based care have been key focuses for WeDoctor in recent years. Team-based care connects hospitals with the physicians handling appointment registrations. Built upon this team-based care framework is a triage system, within which medical consortiums have also seen growth.
4. The Four-Character Mantra for Internet Healthcare: Rigor and Innovation.
Xu Qian of Fosun Pharma: Major platforms will still emerge in internet healthcare, and there will be more than one
1. As capital markets cool and private equity (PE) activity slows, smaller angel investment firms will face impacts on both fundraising and investment activities. From a trend perspective, the ripple effects along the investment chain will gradually extend to early-stage investing.
2. Large platforms will inevitably emerge in the internet healthcare sector. Given the lengthy industry chain and numerous segments, it is possible for three to five such platforms to appear. However, they will not simply replicate existing models. Launching projects similar to Guahao.com or Chunyu Doctor without innovation in business model or technology will make it extremely difficult to surpass established players.
3. Internet healthcare is a cross-disciplinary field. Projects are closely linked to the founders, team DNA, and inherent characteristics; there is no hierarchy among entrepreneurs, as all bring value. The key lies in whether the pace of development can meet expectations and established goals.
4. For internet-based projects, a lightweight business model is a double-edged sword; the balance between the two warrants discussion.
5. A company’s valuation is not necessarily proportional to the founder’s background. I personally do not believe that physicians have an inherent advantage over other entrepreneurs in the digital health sector.
6. I believe the internet healthcare sector holds significant opportunities in areas such as internet hospitals, the deregulation of e-prescriptions, and the integration of commercial insurance with third-party payment systems.
VCBeat’s Cao Yibo: Three Cores, Three Trends
1. Compared with other mobile health initiatives, medical aesthetics is an industry that is more closely aligned with consumers, as other projects primarily target patients.
2. Medical aesthetics is a sector that VCBeat has long favored, though its previous entries were primarily technology-driven.
3. Pain points in China's cosmetic surgery market include: high marketing costs, inadequate hospital evaluation mechanisms, and significant disparities in the scale of plastic surgery institutions.
4. The core mechanisms of medical aesthetics platforms are as follows: first, to verify the qualifications of hospitals and physicians; second, to address information asymmetry; and third, to integrate resources from plastic surgery institutions.
5. The Chinese medical aesthetics market exhibits several unique development trends. For instance, the user base skews younger, with 50% of cosmetic surgery procedures in China performed on individuals aged 20 to 35. Additionally, non-surgical cosmetic procedures have become mainstream, with many providers focusing on enhancing user experience. Thirdly, there is a strong culture of community sharing among consumers.
6. The medical aesthetics sector currently enjoys significant attention from investors, yet challenges persist, such as the inability to curb excessive offline upselling and the lack of clear service standards.
Gengmei’s Liu Di: Aesthetic Medicine—Commonalities and Differences Among Hospitals, Doctors, and Patients
1. Gengmei defines the domain of the consumer healthcare market. The consumer healthcare market comprises health and medical services that are not covered by hospitals or medical insurance, but which healthy individuals are willing to purchase to improve their quality of life, including plastic surgery, dentistry, andrology, obstetrics and gynecology, and other specialties.
2. How to attract China’s top plastic surgeons to the platform? Our approach focuses on understanding the distinct needs of physicians, hospitals, and patients, leveraging internet healthcare platforms to facilitate resource access for all stakeholders.
3. Plastic surgeons possess a high degree of independence; for them, attracting patient volume and generating revenue are of paramount importance. Gengmei’s strategy was to secure the most prominent physicians in the industry, with the first being a leading figure in China’s plastic surgery sector.
4. When operating a medical aesthetics platform, it is essential to convey respect for the industry and demonstrate tangible support to physicians. For consumers, the platform should clearly articulate the specific benefits they can derive from each procedure.
5. Acquiring users has become increasingly challenging; our top priority is to identify where our target audience congregates online. For us, Sina Weibo offers the most cost-effective channel for user acquisition. Furthermore, we must remain highly data-sensitive, evaluating the cost-effectiveness of various platforms to select those best suited to our needs.
Lu Gang from Legend Star: Hospitals Remain Siloed, Physicians Need to Be Mobilized, and Doctor-Patient Conflicts Are Not Merely Communication Issues
1. Has the capital winter arrived? In my view, before answering this question, we should first examine the pain points in healthcare, identify what issues mobile health can address, and determine the current stage of development of mobile health.
2. In the mobile internet sector, high-frequency services displace low-frequency ones, much like how Didi Chuxing eventually encompassed designated driver services for drunk driving.
3. Internet applications must drive traffic; although conversion rates are low, the value of each patient is high.
4. Mobile internet is essentially a highly marketized sector, but healthcare is not an industry that can be fully marketized in any country around the world, as it must balance social equity.
5. In the healthcare sector, investments in Hospital Information Systems (HIS) and Electronic Medical Records (EMR) are also substantial; however, as each hospital develops its own system, the challenge of interoperability remains unresolved.
6. Physicians need to become more mobile; while traditional Chinese medicine (TCM) practitioners are the most adaptable in this regard, their mindset remains the most traditional.
7. Doctor-patient conflicts are not merely issues of communication between doctors and patients. They also involve issues related to social insurance, commercial insurance, payment, and cost control.
8. Mobile healthcare must embrace the perspective that while the future is bright, the path forward will be tortuous. At the core of any business model lies the disruption and restructuring of existing interest structures. Currently, it remains difficult to break the entrenched interest framework dominated by “major Grade-A tertiary hospitals, senior department heads, national health insurance funds, and large pharmaceutical companies.”
9. United Front: Avoid making enemies on multiple fronts; identify the right adversary and focus your strikes (targeting areas with low resistance but high returns). Refrain from reckless talk of disruption; employ vertical and horizontal alliances to secure allies.
10. The wall belongs to public hospitals. The question is whether a company’s positioning is inside the wall, outside the wall, or requires scaling the wall. Operations within the wall are inevitably more complex than those outside; companies that rise during the first wave of development will undoubtedly be those outside the wall.
11. The healthcare industry is relatively resilient; as long as you identify a robust model that effectively addresses critical pain points, survival is likely. Proximity to revenue streams is advantageous, but it requires strategic trade-offs. "De-distortion" is a core value of Legend Star (Lianxiang Zhixing); safeguarding your interests means aligning with ethical and legitimate forces.
12. When designing a business model and engaging in a protracted competition, survival is the top priority. It is essential to manage the pace of development, leverage capital effectively, and maintain moderate cash burn. The key is to achieve results comparable to competitors while spending less than they do.
13. Three Major Future Payment Trends: Pharmaceutical Companies, Medical Insurance, and Out-of-Pocket Payments. With cost containment measures in medical insurance, pharmaceutical companies will have stronger incentives, leading to an increased proportion of out-of-pocket expenses for patients.
14. Positioning: Focus on vertical niches, cultivate distinctive specialties, and engage in intensive, meticulous operations to establish a solid foundation. Avoid premature discussions about building platforms, as their emergence often depends on favorable timing and circumstances. Vertical sectors offer substantial market potential.
Yi Jia Yi's Xu Yi: Four Things Not to Do in Internet Healthcare
1. Every track in internet healthcare is highly saturated, with diverse entry points. Therefore, our team adheres to the “Four Don’ts”: we do not pursue broad-and-comprehensive offerings; we do not enter low-barrier markets; we do not address weak demands; and we do not engage in projects that focus on user acquisition without achieving profitability.
2. Oncology is an ideal niche market, characterized by numerous pain points, limited competition, substantial market size, a clear growth trajectory, high barriers to entry, and price-insensitive users.
3. The distinction between pre- and post-diagnosis for cancer patients is not absolute; therefore, our objective is to address the low frequency of pre-diagnosis engagement and the closed access points in post-diagnosis care.
4. To address the issue of low frequency, we optimize post-consultation features; to build competitive barriers, we adopt a capital-intensive business model that involves in-person physician recruitment, offline user acquisition, and deep backend operational involvement.
5. For early-stage projects, it is best to temporarily avoid partnering with pharmaceutical companies, as their stringent requirements often force projects into highly customized arrangements. Our current objective is to reach the opposite summit as quickly as possible; do not pick up money along the way unless it requires virtually no effort. Only take what comes easily; if it demands any significant exertion, leave it be.
6. Vertical domains offer numerous monetization models, such as doctor-patient service models, resource-matching solutions tailored to user needs, and small-data analytics.
Micro-Nano Core’s Wang Zhanhui: The Challenge of Tiered Diagnosis and Treatment Is the Challenge of Primary Healthcare
1. We are developing an intelligent medical diagnostic system based on microfluidics technology. In the coming years, microfluidics-based testing devices may enter clinical practice and even reach the household level.
2. Traditionally, analysis was performed using various bottles and containers. Now, the analytical reaction process has been shifted to microfluidics, enabling the supporting equipment to be made extremely small and portable—even wearable. This is its greatest advantage.
3. Tiered diagnosis and treatment primarily addresses challenges at the primary care level, focusing on two key areas: talent development and the utilization of specialized diagnostic equipment. Integrating professional, medical-grade therapeutic hardware with online healthcare services, and combining specialized diagnostic devices with remote physician consultations, may help alleviate this issue to a certain extent.
Bi Lei of Chunyu Doctor: Nothing Is Set in Stone; the Internet Requires Rapid Trial and Error
1. Mobile healthcare is a process of transitioning from surplus to restructuring. It integrates patients’ fragmented time and fragmented needs with doctors’ fragmented time and fragmented services.
2. Internet companies must engage in rapid trial and error, adhering to the Disruptor’s Law: uncovering new users among non-consumers and creating new demands. Only by analyzing within a new value system can new growth opportunities be identified.
3. Within the healthcare system comprising insurers, government entities, hospitals, physicians, and retail pharmacies, we identify the following medical opportunities: lightweight consultations (rebuilding the value network), self-diagnosis (leveraging artificial intelligence), and private physicians (reengineering healthcare processes).
4. Understanding of Tiered Diagnosis and Treatment: China lacks general practitioners; the healthcare system is characterized solely by the relationship between patients and hospitals, rather than between doctors and patients. Furthermore, the tiered medical system remains underdeveloped due to the competitive, rather than collaborative, relationship between tertiary (Grade III) and secondary (Grade II) hospitals.
5. Chunyu’s O+O Hospital Model: Online-Offline Collaboration, Not Mere Traffic Diversion. Traffic generation holds limited value, whereas the collaborative model delivers substantive service value.
6. The Chinese insurance industry has underperformed, with health insurance serving only as a supplementary coverage. It is difficult to accurately price the diverse range of health insurance products through actuarial methods. Furthermore, tertiary hospitals (Grade 3A) hold excessive market power, concentrating all levels of healthcare services—high, medium, and low—within their facilities. This centralization makes service delivery unmanageable and unoptimizable, leaving insurance companies with little bargaining power.
7. An innovative team is one that builds from scratch (0 to 1). The pharmaceutical industry features complex and ever-evolving business models, while the two-sided subsidy model of mobile health platforms is even more intricate and costly. Assembling multidisciplinary teams is challenging; true guidance lies in complementary expertise, with people being the sole determinant of success.
8. China’s business model, characterized by “subsidizing healthcare with pharmaceutical profits,” shifts from monetizing traffic to user operations, creating user-oriented product usage scenarios, and making product sales a component of commercial services rather than the end goal.
9. Medical Services Required by Users: Symptom acquisition is a prerequisite for disease diagnosis; precision medicine facilitates the separation of diagnosis and treatment; specialized platforms can enhance treatment efficiency; online medical services significantly reduce healthcare costs; matching with offline hospitals enables rational resource utilization; and data monitoring enables personalized medicine.
10. Restructuring Offline Medical Services: Patient + Doctor, Chunyu Air Hospital; Patient + Doctor + Hospital: Chunyu Clinics and Chunyu Hospitals.
Sequoia Capital’s Chen Penghui: Entrepreneurs Change the World; Investors Must Understand Entrepreneurs
1. As investors, it is entrepreneurs and business founders who truly change the world. Therefore, the perspective should be reversed: investors ought to understand entrepreneurial thinking.
2. Good capital not only provides funding but also facilitates access to high-quality resources.
3. In the first two years after any new technology emerges, the public and investors tend to overestimate its adoption rate and impact on the world; later, it becomes apparent that the technology’s influence is not as significant as initially perceived. I believe this observation also applies to the internet healthcare industry.
4. The timeline for the “capital winter” in internet healthcare should be viewed over a longer horizon; more unicorn companies will undoubtedly emerge in the future. Enterprises with strong rapid-learning capabilities, those that can swiftly identify new business models, and those that quickly address user pain points are certain to succeed.
5. There is no need to be overly pessimistic about internet healthcare; finding the right direction in three to five years may not be too late. Entrepreneurs should not worry about how investors view internet healthcare, as it is entrepreneurs, not investors, who change the world.
6. The current patient volume at private hospitals remains relatively low; however, multi-site practice, physician groups, and mobile health will all inject significant new momentum into the development of private hospitals. I am uncertain what percentage of China’s total healthcare services private hospitals will account for in the future, but it will certainly exceed 10%. My hope is that it will reach 50% or higher.
—————— Highlights of Guest Speeches from the Xingdong Xiangyihui Open Course ——————